Premium
The launch of Ayushman Bharat—touted as the world’s largest state-sponsored health insurance scheme—and a billion-dollar hospital deal after aggressive bidding and a dash of controversy made 2018 momentous for the Indian healthcare industry. The year also saw the biggest outbound pharmaceuticals transaction by an Indian company, underlining domestic drugmakers’ persistent overseas ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
